PUBLICATION
Zebrafish as an Emerging Model for Bioassay-Guided Natural Product Drug Discovery for Neurological Disorders
- Authors
- Pitchai, A., Rajaretinam, R.K., Freeman, J.L.
- ID
- ZDB-PUB-190604-5
- Date
- 2019
- Source
- Medicines (Basel, Switzerland) 6(2): (Review)
- Registered Authors
- Freeman, Jennifer
- Keywords
- Alzheimer’s disease, Parkinson’s disease, bioassay-guided purification, drug discovery, natural products, neurodegenerative disorder, neurodegenerative model, schizophrenia, transgenic, zebrafish
- MeSH Terms
- none
- PubMed
- 31151179 Full text @ Medicines (Basel)
Citation
Pitchai, A., Rajaretinam, R.K., Freeman, J.L. (2019) Zebrafish as an Emerging Model for Bioassay-Guided Natural Product Drug Discovery for Neurological Disorders. Medicines (Basel, Switzerland). 6(2).
Abstract
Most neurodegenerative diseases are currently incurable, with large social and economic impacts. Recently, there has been renewed interest in investigating natural products in the modern drug discovery paradigm as novel, bioactive small molecules. Moreover, the discovery of potential therapies for neurological disorders is challenging and involves developing optimized animal models for drug screening. In contemporary biomedicine, the growing need to develop experimental models to obtain a detailed understanding of malady conditions and to portray pioneering treatments has resulted in the application of zebrafish to close the gap between in vitro and in vivo assays. Zebrafish in pharmacogenetics and neuropharmacology are rapidly becoming a widely used organism. Brain function, dysfunction, genetic, and pharmacological modulation considerations are enhanced by both larval and adult zebrafish. Bioassay-guided identification of natural products using zebrafish presents as an attractive strategy for generating new lead compounds. Here, we see evidence that the zebrafish's central nervous system is suitable for modeling human neurological disease and we review and evaluate natural product research using zebrafish as a vertebrate model platform to systematically identify bioactive natural products. Finally, we review recently developed zebrafish models of neurological disorders that have the potential to be applied in this field of research.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping